DuPont (NYSE: DD) is to acquire the Memcor® business including ultrafiltration and membrane biofiltration technologies from Evoqua Water Technologies Corp.
The deal is expected to close by the end of 2019, subject to customary closing conditions and regulatory approvals.
The Evoqua ultrafiltration and membrane biofiltration (MBR) technologies add to DuPont’s portfolio of water purification and separation capabilities including ultrafiltration, reverse osmosis and ion exchange resins. Together with the intended acquisition of BASF’s ultrafiltration business, which is also expected to close by the end of 2019 subject to customary closing conditions and regulatory approvals, DuPont will be positioned to provide the products, technology and geographic diversification needed to meet customer demand.
DuPont (NYSE: DD) is a global innovation leader in technology-based materials, ingredients and solutions for key markets including electronics, transportation, construction, water, health and wellness, food and worker safety.